ICU Acquired Weakness: Clinical Trials

47 trials for ICU Acquired Weakness, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

15 completed, 13 unknown, 10 recruiting, 4 terminated. 19 Not applicable, 1 Early Phase 1, 1 Phase 2, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable19Recruiting 8, Unknown 5, Completed 4, Terminated 2
Early Phase 11Not yet recruiting 1
Phase 21Terminated 1
Phase 41Active not recruiting 1

Follow ICU Acquired Weakness: new trials by email Literature Review of ICU Acquired Weakness trials Research Report on ICU Acquired Weakness

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Protein, Mobility Therapy and Electric Stimulation on Recovery in Older ICU Survivors
MRP and High Protein Supplement (HPRO) and Neuromuscular Electric Stimulation (NMES) - Critical Illness, Sarcopenia
Early Phase 1Not yet recruitingUniversity of Maryland, Baltimore782027-03-012026-05-06
ICU CONNECT: Study Comparing EMG in Healthy Volunteers and ICU Patients.
TetraGraph, Electromyography, Nerve conduction studies - ICU Acquired Weakness
Not applicableRecruitingEndeavor Health242026-06-012026-07-13
Development of an Early Warning Model for Intensive Care Unit-Acquired Weakness in Mechanically Ventilated Children
ICU-AW - ICU Acquired Weakness
Enrolling by invitationChildren's Hospital of Fudan University15002026-03-012026-03-19
Exploring Novel Biomarkers of ICU-AW in Mechanically Ventilated Children at the Molecular Level
ICU-AW - ICU Acquired Weakness
Enrolling by invitationChildren's Hospital of Fudan University5002026-03-012026-03-19
Predictive Validity of the Chelsea Critical Care Physical Assessment Tool (CPAx) for Regaining Autonomy Three Months After ICU Discharge
CPAx - ICU Acquired Weakness, Intensive Care Neuropathy
Active not recruitingCentre Hospitalier Intercommunal Elbeuf-Louviers-Val de Reuil292025-09-012026-09-02
Effect of the "Sitting Out of Bed in an Arm-chair Position" in ICU on Functional Recovery Among Ventilated Patients
sitting out of bed in an arm-chair position - ICU Acquired Weakness
Not applicableRecruitingCentre Hospitalier Régional d'Orléans1502025-07-042025-12-19
ICU-Recover Box 2.0, Smart Technology for Home Monitoring of ICU Patients
The ICU-Recover Box: using smart technology for monitoring health status after ICU admission Pilot 2.0 - ICU Acquired Weakness
Not applicableRecruitingLeiden University Medical Center502025-07-012025-09-29
TESTO-TRIAL: Use of Testosterone in Critically Ill Patients
Testosterone cypionate (200mg/3ml), Sesame oil (3ml) - Weaning Failure, Muscle Weakness
Phase 4Active not recruitingLeticia Maria Defendi Barboza Marson942024-09-092024-12-18
Behavioral Economic & Staffing Strategies in the ICU
Realtime audit and feedback, RN Implementation Facilitator - Implementation Science, Delirium
Not applicableRecruitingUniversity of Nebraska165002024-07-012026-09-29
Hand and Arm Rehabilitation Using VR
VR training for arm and hand rehabilitation - Post-Intensive Care Syndrome, ICU Acquired Weakness
Not applicableRecruitingFrisius Medisch Centrum1082024-01-152024-04-18
ICU Combined Assessment of Cardio-Respiratory Exercise
ICU Acquired Weakness, Sepsis
RecruitingUniversity of Manitoba502023-12-152026-06-15
Prone Positioning and Thoracoabdominal Binding on Lung and Muscle Protection in ARDS Patients During Spontaneous Breathing
Prone Positioning, Thoracoabdominal Binding, Control - Acute Respiratory Distress Syndrome, Mechanical Ventilation Complication
Not applicableTerminatedUniversity of Chile142023-12-062026-09-28
Evaluation of Diaphragmatic Function and Quadriceps Muscle Thickness in Patients Receiving High Protein Nutrition
patients who will receive 2 gm protein/kg/day will be evaluated by ultrasound for diaphragmatic function and quadriceps muscle thickness - ICU Acquired Weakness
Not applicableUnknownZagazig University322023-10-012023-09-14
Safety and Efficacy of the MyokinE100 (CL-EMS Alpha) Device in Inducing Visible Muscle Contraction in Healthy Volunteers
Electrical muscle stimulation - ICU Acquired Weakness
Not applicableCompletedHealth Discovery Labs82023-08-222023-09-26
Improved Muscle Metabolism by Combination of Muscle Activation and Protein Substitution ( IMEMPRO )
Dietary Supplement: additional substitution of protein, Neuromuscular electrical stimulation, Early Mobilization - ICU Acquired Weakness, Muscle Atrophy
Not applicableRecruitingTechnical University of Munich402023-06-272026-03-03
Optimised Nutritional Therapy and Early Physiotherapy in Long Term ICU Patients (NutriPhyT Trial)
Optimisation of nutrition therapy coupled with early mobilisation, Standard care - Critical Illness, ICU Acquired Weakness
Not applicableRecruitingHEIDEGGER CP1642023-05-012025-08-12
REmotely Monitored, Mobile Health Supported Multidomain Rehabilitation Program With High Intensity Interval Training for COVID-19
REmotely monitored, Mobile health supported Multidomain Rehabilitation Program with High Intensity Interval Training (REMM-HIIT) - COVID-19, Critical Illness
Not applicableRecruitingDuke University1202023-02-232026-05-28
5 Years Quality of Life and Early Mobilization in ICU
Questionnaires - Quality of Life, ICU Acquired Weakness
CompletedCentre Hospitalier Régional d'Orléans1382022-10-282023-05-17
Muscle Recovery After Critical Illness
ICU Acquired Weakness, Post Intensive Care Unit Syndrome
RecruitingEsther Dupont-Versteegden2092022-10-182026-06-26
Muscle Catabolism and Outcomes in Children Following Cardiac Surgery
Muscle ultrasound to estimate lean body mass - Congenital Heart Disease, ICU Acquired Weakness
UnknownBoston Children's Hospital642022-07-152023-07-19

Showing 20 of 47. Sign in to see all of them.

Narrower conditions

Critical Illness (11)  ·  COVID-19 (3)  ·  Muscle Weakness (3)  ·  Sarcopenia (3)  ·  postintensive care syndrome (3)  ·  Malnutrition (2)  ·  Muscular Atrophy (2)  ·  Accidental Injuries (1)  ·  Acute Lung Injury (1)  ·  Asthenia (1)  ·  Constipation (1)  ·  Delirium (1)  ·  Diarrhea (1)  ·  Heart Defects, Congenital (1)  ·  Liver Failure (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (16)  ·  Pathologic Processes (12)  ·  Disease Attributes (11)  ·  Nervous System Diseases (11)  ·  Signs and Symptoms (10)  ·  Neurologic Manifestations (9)  ·  Neuromuscular Manifestations (8)  ·  Atrophy (5)  ·  Infections (5)  ·  Pathological Conditions, Anatomical (5)  ·  Respiratory Tract Diseases (5)  ·  Lung Diseases (4)  ·  Musculoskeletal Diseases (4)  ·  Coronaviridae Infections (3)  ·  Coronavirus Infections (3)

Interventions

Nerve Conduction Studies (2)  ·  Early Ambulation (1)  ·  Electromyography (1)  ·  High-Intensity Interval Training (1)  ·  Intensive Care Units (1)  ·  Muscle Relaxation (1)  ·  Physical Therapy Modalities (1)  ·  Prone Position (1)  ·  Rehabilitation (1)  ·  Sesame Oil (1)  ·  Standard of Care (1)  ·  Surveys and Questionnaires (1)  ·  testosterone 17 beta-cypionate (1)

Sponsors

Centre Hospitalier Régional d'Orléans (2)  ·  Children's Hospital of Fudan University (2)  ·  Groupe Hospitalier du Havre (2)  ·  University Hospital, Montpellier (2)  ·  Ain Shams University (1)  ·  Assiut University (1)  ·  Azienda Sanitaria-Universitaria Integrata di Udine (1)  ·  B.P. Koirala Institute of Health Sciences (1)  ·  Boston Children's Hospital (1)  ·  Centre Hospitalier Intercommunal Elbeuf-Louviers-Val de Reuil (1)  ·  Centre Hospitalier Universitaire Vaudois (1)  ·  Centro Universitário Augusto Motta (1)  ·  Chinese PLA General Hospital (1)  ·  Community Health System (1)  ·  Duke University (1)

Countries

United States (11)  ·  France (9)  ·  China (5)  ·  Switzerland (3)  ·  Brazil (2)  ·  Canada (2)  ·  Egypt (2)  ·  Netherlands (2)  ·  Taiwan (2)  ·  Turkey (Türkiye) (2)  ·  Australia (1)  ·  Austria (1)  ·  Belgium (1)  ·  Chile (1)  ·  Germany (1)

Top investigators

Asher Mendelson, MD PhD (1)  ·  Ayman Amer, professor (1)  ·  Claudia Heidegger, MD (1)  ·  Cliodhna Ashe, MD (1)  ·  Esra Pehlivan, Ass.Prof (1)  ·  Ghada Abdelrazik, professor (1)  ·  Hakan Parlak, MD (1)  ·  Huan-Jui Yeh (1)  ·  Hung-Jui Chuang, Dr (1)

Results publications

PMID 11904668, PMID 12186831, PMID 12472328, PMID 12594312, PMID 1593914, PMID 16984837, PMID 17855814, PMID 18367735, PMID 18388161, PMID 18511703, PMID 20639440, PMID 20843245, PMID 20959786, PMID 21939902, PMID 22392031, PMID 22835162, PMID 2306029, PMID 23219649, PMID 23344830, PMID 24669784, PMID 24949192, PMID 24993976, PMID 25886857, PMID 26167730, PMID 27259819, PMID 27492005, PMID 27864615, PMID 28698263, PMID 28787181, PMID 30043066, PMID 31970446, PMID 32014005, PMID 32269085, PMID 32915072, PMID 34255974, PMID 34805212, PMID 35767435, PMID 37739681, PMID 38330169, PMID 38778416, PMID 40114068, PMID 41263932, PMID 41388315, PMID 42446403

NIH funding

1UG3HL165740-01A1 (1), 4UH3HL165740-02 (1), K23AR079583 (1), R01AR081002 (1), R01HD107103 (1)